The Cancer Convergence is reputed journal publishes research related to oncology, cancer initiation, tumour progression, cancer treatment strategies. The ISSN of the journal is 2366-6196.
Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.
| Journal Title | Cancer Convergence |
|---|---|
| Publisher | BMC |
| Publication Country | United Kingdom |
| ISSN | 2366-6196 |
| Publication Area | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Publication Language | English |
| Review Process | Anonymous peer review |
| Scopus Indexed | No |
The Cancer Convergence is indexed in: DOAJ.
There is a fee to publish in the Cancer Convergence. The publication fee is 1140 EUR; 1340 USD; 1040 GBP.
The journal also offers a fee waiver policy.
The Cancer Convergence takes an average of 36 weeks to publish research papers.
The official website of the journal is https://cancerconvergence.biomedcentral.com/.
Please visit only official website of the journal to submit research papers.